Drug Profile
Research programme: Src-ND2 inhibitors - NoNO
Latest Information Update: 28 Nov 2020
Price :
$50
*
At a glance
- Originator NoNO
- Class Analgesics; Anti-inflammatories
- Mechanism of Action Protein-protein interaction inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammation; Neuropathic pain
Most Recent Events
- 28 Nov 2020 No recent reports of development identified for preclinical development in Inflammation in Canada
- 28 Nov 2020 No recent reports of development identified for preclinical development in Neuropathic-pain in Canada
- 26 Oct 2016 Preclinical trials in Inflammation in Canada (unspecified route)